8 results
Stroke and bleeding risk stratification with the CHADS2-VASc and HAS-BLED schemas

#Diagnosis #Hematology #CHADS2 #CHADS2VASc #HASBLED #Comparison
Stroke and bleeding ... schemas #Diagnosis ... #Hematology #CHADS2 ... #Stroke #Bleed ... #Anticoagulation
Lower Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Active Bleeding

#LowerExtremity #Veins #Venous #Thrombosis
Superficial - Active Bleeding ... Superficial #Deep #VTE ... #DVT #Hematology ... #Anticoagulation ... #Algorithm
Bleeding risk calculators - HAS-BLED (atrial fibrillation) and IMPROVE (VTE prophylaxis for inpatients)
Important notes:
 • No
Bleeding risk calculators ... - HAS-BLED (atrial ... ) and IMPROVE (VTE ... #Factors #Hematology ... #Diagnosis
CHA2DS2VASc vs HAS-BLED scores for stroke risk and bleed risk on anticoagulation

C	Congestive Heart Failure	1

H	Hypertension	1

A2	Age >75	2

D	Diabetes Mellitus	1

S2	Stroke,
risk and bleed ... risk on anticoagulation ... 1 B Bleeding ... #Stroke #Bleed ... #Hematology
Approach to the Hypercoagulable State
Arterial thromboembolism
→ Cardiac rhythm monitoring, Echocardiogram, Vascular imaging
→ Test for APS, particularly
history of prior venous ... are not a major risk ... - Strong Medicine ... #diagnosis #algorithm ... #hematology #VTE
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Longterm Venous ... PE - High Bleeding ... therapy - Second VTE ... #management #hematology ... #anticoagulation
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
event, follow ACC algorithm ... Anticoagulation ... - what is the bleeding ... • <6mo since stroke ... • <3mo since VTE
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
• Treatment algorithms ... patients with no CV risk ... Hydroxyurea + anticoagulation ... (if history of venous ... #hematology